KERAN HILL: Open Payments
NPI 1407917289 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 12 payments from 4 companies in 2025. Trend: 2023 $464 · 2024 $276 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 6 | $139 |
| ABBVIE INC. | 4 | $67 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| ACADIA Pharmaceuticals Inc | 1 | $24 |
Products named: MAVYRET, COBENFY, NUPLAZID.
Industry payments across NY — which companies pay providers there.
